Log in   |   Join the community   



Posted by 05.09.13

On May 2, the members of the FDA’s General and Plastic Surgery Devices Panel gave their nod to Allergan’s Juvéderm® Voluma® XC  for the correction of age-related volume loss in the midface. Although Voluma still has to get through the FDA clearance phase, a recommendation from its advisory panel is a good sign. Voluma is well positioned to be the first NEW wrinkle filler to be launched in the US market in 2013, although it is already approved in 65 countries, including Canada.

So what’s new about Voluma? The name says it all. Voluma is intended to add volume to creases, deep folds, and areas in need of enhancement, such as cheeks and chins. It is used in Cana

Read More


  • Созраняй чтоб не потерять

We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.